Cyberattacks Remain Serious Threat to Health Providers

Share this content:
Cyberattacks Remain Serious Threat to Health Providers
Cyberattacks Remain Serious Threat to Health Providers

THURSDAY, Feb. 23, 2017 (HealthDay News) -- Cyberattacks remain a serious threat to small providers as well as big institutions, according to a report published in Medical Economics.

The authors note that cyberattacks are becoming more sophisticated, targeting medical devices that are networked with electronic health records (EHRs) and other health care applications, as well as smartphones. Small practices are also being targeted, with hackers assuming (often correctly) that their security is weaker.

According to the report, software should segregate levels of access to EHRs, allowing only authorized personnel to access health records, and monitoring and reporting who accesses records. Processes and technology should be boosted against evolving cyberthreats. Staff should change passwords regularly in order to prevent phishing attacks. Newer threats can be counteracted with additional technologies, including software that prevents USB drives from being used, mobile device management software that secures mobile devices, and secure platforms that allow for encrypted texting and data sharing. Cloud-based EHRs should be considered, as cloud providers have more resources to focus on security. Physicians should document their security measures to ensure they are being followed and to prove that they took adequate steps in the event of a breach.

"Documentation isn't just writing it down," Karen McMillen, CISSP, a security risk analyst with Asante, said in the article. "Some of this documentation happens automatically, such as [records] back-up that's documented electronically. That can demonstrate compliance."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »